peptide drugs

RFK Jr. Appoints Peptide Advocates to FDA Advisory Panel

Robert F. Kennedy Jr. has appointed nine new members, many with financial ties or personal promotion of peptide drugs, to an FDA advisory panel. This move comes as the panel is set to review the accessibility of these unproven drugs, despite FDA scientists' concerns about safety and efficacy.